Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Robert Williams, Jr. Sells 3,000,000 Shares

Posted by George Bondi on Jul 3rd, 2026

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) major shareholder Robert Williams, Jr. sold 3,000,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total value of $24,030,000.00. Following the transaction, the insider directly owned 190,130 shares in the company, valued at $1,522,941.30. The trade was a 94.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Trading Up 2.7%

Shares of Aveanna Healthcare stock opened at $9.10 on Friday. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. The business has a fifty day simple moving average of $7.31 and a two-hundred day simple moving average of $7.56. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.73 and a 1 year high of $10.32. The company has a market capitalization of $1.98 billion, a price-to-earnings ratio of 7.71, a P/E/G ratio of 0.91 and a beta of 1.89.

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.13 by $0.05. The firm had revenue of $647.91 million for the quarter, compared to the consensus estimate of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm’s quarterly revenue was up 15.9% on a year-over-year basis. Research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current year.

Hedge Funds Weigh In On Aveanna Healthcare

Hedge funds have recently bought and sold shares of the business. Dynamic Technology Lab Private Ltd increased its stake in Aveanna Healthcare by 8.9% in the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after acquiring an additional 1,151 shares during the last quarter. Barclays PLC boosted its holdings in shares of Aveanna Healthcare by 0.8% in the 3rd quarter. Barclays PLC now owns 179,359 shares of the company’s stock valued at $1,591,000 after purchasing an additional 1,366 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of Aveanna Healthcare by 4.5% in the 3rd quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock valued at $316,000 after purchasing an additional 1,528 shares in the last quarter. Intech Investment Management LLC increased its stake in shares of Aveanna Healthcare by 9.8% in the 4th quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock valued at $159,000 after purchasing an additional 1,739 shares during the last quarter. Finally, Balboa Wealth Partners increased its stake in shares of Aveanna Healthcare by 13.5% in the 4th quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock valued at $138,000 after purchasing an additional 2,007 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms have weighed in on AVAH. BMO Capital Markets lowered their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a report on Friday, March 20th. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a report on Wednesday, June 3rd. Raymond James Financial raised Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price on the stock in a research report on Friday, March 20th. Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. Finally, Truist Financial lifted their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Aveanna Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $10.50.

Check Out Our Latest Stock Analysis on Aveanna Healthcare

Aveanna Healthcare Company Profile

(Get Free Report)

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.